+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CRISPR Therapeutics"

Crispr Technology Market 2022-2026 - Product Thumbnail Image

Crispr Technology Market 2022-2026

  • Report
  • May 2022
  • Global
From
From
From
From
From
From
From
From
Gene Therapy-Competitive landscape, 2023 - Product Thumbnail Image

Gene Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Gene Editing Tools Market - Product Thumbnail Image

Gene Editing Tools Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Gene Delivery Technologies Market - Product Thumbnail Image

Gene Delivery Technologies Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
CRISPR Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

CRISPR Market - Forecasts from 2021 to 2026

  • Report
  • July 2021
  • 112 Pages
  • Global
From
From
From
Loading Indicator

CRISPR Therapeutics is a rapidly growing field within the genomics market. It is a gene-editing technology that uses a modified version of the CRISPR-Cas9 system to modify or replace genes in a living organism. This technology has the potential to revolutionize the way diseases are treated, as it can be used to target and modify specific genes that are responsible for certain diseases. It can also be used to create new treatments for diseases that have no existing treatments. CRISPR Therapeutics has been used to develop treatments for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. It has also been used to create new treatments for rare diseases, as well as to develop new therapies for existing diseases. Companies in the CRISPR Therapeutics market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences. These companies are working to develop treatments for a variety of diseases, as well as to create new therapies for existing diseases. Show Less Read more